Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03634579 · ClinicalTrials.gov registry record · NA
MRI Guided Prostate Cancer Focal Laser Ablation
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03634579: Clinical Trial NA study, sponsored by Emory University.
NCT03634579 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03634579, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The study is a prospective, single-arm, non-randomized, unblinded trial to determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate risk prostate cancer. All subjects meeting the inclusion exclusion criteria and are enrolled will undergo a MRI guided focal laser ablation procedure. The primary aim of the study is to study the safety and efficacy of the procedure.
Primary Outcome
Efficacy is assessed by recurrence rate at 1 year, defined as the number of recurrences divided by the number of patients treated with MRI Guided Focal Laser Interstitial Thermal Ablation
Interventions
- DEVICE MRI Guided Focal Laser Interstitial Thermal Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2019-03-15 |
| Phase | NA |
Why NCT03634579 stopped before completion
NCT03634579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which MRI Guided Focal Laser Interstitial Thermal Ablation is the first listed.
NCT03634579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03634579 about?
NCT03634579 is a clinical study titled "MRI Guided Prostate Cancer Focal Laser Ablation". The study is a prospective, single-arm, non-randomized, unblinded trial to determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate risk prostate cancer. All subjects meeting the inclusion exclusion criteria and are enrolled will undergo a MRI guided foc...
What is the current status of trial NCT03634579?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-06-01. Estimated completion is 2019-03-15.
What interventions are being tested in trial NCT03634579?
The interventions under investigation include: MRI Guided Focal Laser Interstitial Thermal Ablation (DEVICE).
Who is sponsoring clinical trial NCT03634579?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03634579's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI